OncoSec announces two appointments to its clinical team: Dr. Paul Goldfarb and Ernest Kitt.
Dr. Paul Goldfarb assumes the role of medical director, advising the Company’s clinical and regulatory affairs department on all clinical programs. Dr. Goldfarb brings more than 40 years of expertise as a surgical oncologist and practicing physician. He is also the author of numerous peer-reviewed articles related to the use of electroporation to deliver bleomycin in solid tumors and other ablative technologies for the treatment of cancer
Ernest Kitt becomes executive director, clinical operations. He brings 15 years of industry experience in clinical research and operations, including the management of early and late stage oncology programs for established biotechnology companies including Medicinova and Vical.